Belgium · Series A startup

Who invested in ATB Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$57Mraised across 1 round since 2024, from 1 source

Latest round
Series A, $57MNov 2024
Investors
1
See who backed them

The rounds

  1. Nov 2024
    Series A$57M

    Source recorded

Everyone who backed them

EQT Life SciencesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list ATB Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

V-Bio VenturesVC firmPer its own site
SFPIMVC firmPer its own site

Quick answers about ATB Therapeutics

Who invested in ATB Therapeutics?

ATB Therapeutics's investors include EQT Life Sciences.

How much has ATB Therapeutics raised?

ATB Therapeutics has raised $57M across 1 round since 2024.

When did ATB Therapeutics last raise?

ATB Therapeutics's most recent round was a Series A of $57M in Nov 2024.

What was ATB Therapeutics's biggest round?

Its most recent round, $57M in Nov 2024, is also its largest on record.

Who backed ATB Therapeutics first?

ATB Therapeutics's first round on record, in Nov 2024, was backed by EQT Life Sciences.

What stage is ATB Therapeutics at?

ATB Therapeutics's latest named round is a Series A, in Nov 2024.

Where is ATB Therapeutics based?

ATB Therapeutics is based in Belgium.

Companies like ATB Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.